JDD December 2023 Issue Highlights
Welcome to the December 2023 issue of the Journal of Drugs in Dermatology (JDD), where cutting-edge research and advancements in the field of dermatology take center stage. This issue brings together a diverse array of original articles, case reports, brief communications, and letters to the editor and delves into the latest developments, therapeutic breakthroughs, and cl …
Welcome to the December 2023 issue of the Journal of Drugs in Dermatology (JDD), where cutting-edge research and advancements in the field of dermatology take center stage. This issue brings together a diverse array of original articles, case reports, brief communications, and letters to the editor and delves into the latest developments, therapeutic breakthroughs, and cl … 
With a special focus on psoriasis, the August issue of the Journal of Drugs in Dermatology features an outstanding editorial line-up with articles, features, and case reports on topics ranging from antihistamines in psoriasis, facial erythema in rosacea, management of AKs, to herpes zoster following COVID-19 vaccination, cutaneous angiosarcoma of the scalp, and everything in between! Straight fr … 
The patient had an extensive superficial basal cell carcinoma on the forehead treated with topical imiquimod and returned 4-weeks later with this reaction. Which cytokine is not activated by this medication?
A. Tumor necrosis factor (TNF)-α
B. Interferon (IFN)-α
C. Interferon (IFN)-γ
D. Interleukin (IL)-12
E. Interleukin (IL)-4
To find out the correct answer and read the explanation … 